Literature DB >> 18392748

Pathogenesis of CNS involvement in disorders of amino and organic acid metabolism.

S Kölker1, S W Sauer, G F Hoffmann, I Müller, M A Morath, J G Okun.   

Abstract

Inherited disorders of amino and organic acid metabolism have a high cumulative frequency, and despite heterogeneous aetiology and varying clinical presentation, the manifestation of neurological disease is common. It has been demonstrated for some of these diseases that accumulating pathological metabolites are directly involved in the manifestation of neurological disease. Various pathomechanisms have been suggested in different in vitro and in vivo models including an impairment of brain energy metabolism, an imbalance of excitatory and inhibitory neurotransmission, altered transport across the blood-brain barrier and between glial cells and neurons, impairment of myelination and disturbed neuronal efflux of metabolic water. This review summarizes recent knowledge on pathomechanisms involved in phenylketonuria, glutaric aciduria type I, succinic semialdehyde dehydrogenase deficiency and aspartoacylase deficiency with examples, highlighting general as well as disease-specific concepts and their putative impact on treatment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18392748     DOI: 10.1007/s10545-008-0823-z

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  114 in total

1.  Dark-rearing delays the loss of NMDA-receptor function in kitten visual cortex.

Authors:  K Fox; N Daw; H Sato; D Czepita
Journal:  Nature       Date:  1991-03-28       Impact factor: 49.962

2.  Roles of NR2A and NR2B in the development of dendritic arbor morphology in vivo.

Authors:  Rebecca C Ewald; Kendall R Van Keuren-Jensen; Carlos D Aizenman; Hollis T Cline
Journal:  J Neurosci       Date:  2008-01-23       Impact factor: 6.167

3.  Acute extrapyramidal syndrome in methylmalonic acidemia: "metabolic stroke" involving the globus pallidus.

Authors:  R Heidenreich; M Natowicz; B E Hainline; P Berman; R I Kelley; R E Hillman; G T Berry
Journal:  J Pediatr       Date:  1988-12       Impact factor: 4.406

4.  Evidence for central nervous system glial cell plasticity in phenylketonuria.

Authors:  C A Dyer; A Kendler; T Philibotte; P Gardiner; J Cruz; H L Levy
Journal:  J Neuropathol Exp Neurol       Date:  1996-07       Impact factor: 3.685

5.  Long-term treatment of patients with mild and classical phenylketonuria by tetrahydrobiopterin.

Authors:  Friedrich K Trefz; Dagmar Scheible; Georg Frauendienst-Egger; Herbert Korall; Nenad Blau
Journal:  Mol Genet Metab       Date:  2005-10-20       Impact factor: 4.797

6.  Long-term changes in glutamatergic synaptic transmission in phenylketonuria.

Authors:  A V Glushakov; O Glushakova; M Varshney; L K Bajpai; C Sumners; P J Laipis; J E Embury; S P Baker; D H Otero; D M Dennis; C N Seubert; A E Martynyuk
Journal:  Brain       Date:  2005-01-05       Impact factor: 13.501

7.  Individual blood-brain barrier phenylalanine transport in siblings with classical phenylketonuria.

Authors:  J Weglage; D Wiedermann; J Denecke; R Feldmann; H G Koch; K Ullrich; H E Möller
Journal:  J Inherit Metab Dis       Date:  2002-10       Impact factor: 4.982

8.  Clinical spectrum of succinic semialdehyde dehydrogenase deficiency.

Authors:  P L Pearl; K M Gibson; M T Acosta; L G Vezina; W H Theodore; M A Rogawski; E J Novotny; A Gropman; J A Conry; G T Berry; M Tuchman
Journal:  Neurology       Date:  2003-05-13       Impact factor: 9.910

9.  Decline of acute encephalopathic crises in children with glutaryl-CoA dehydrogenase deficiency identified by newborn screening in Germany.

Authors:  Stefan Kölker; Sven F Garbade; Nikolas Boy; Esther M Maier; Thomas Meissner; Chris Mühlhausen; Julia B Hennermann; Thomas Lücke; Johannes Häberle; Jochen Baumkötter; Wolfram Haller; Edith Muller; Johannes Zschocke; Peter Burgard; Georg F Hoffmann
Journal:  Pediatr Res       Date:  2007-09       Impact factor: 3.756

Review 10.  The basic science of memory as it applies to epilepsy.

Authors:  Kimford J Meador
Journal:  Epilepsia       Date:  2007       Impact factor: 5.864

View more
  20 in total

1.  Rare Late-Onset Presentation of Glutaric Aciduria Type I in a 16-Year-Old Woman with a Novel GCDH Mutation.

Authors:  M J Fraidakis; C Liadinioti; L Stefanis; A Dinopoulos; R Pons; M Papathanassiou; J Garcia-Villoria; A Ribes
Journal:  JIMD Rep       Date:  2014-09-26

Review 2.  Food products made with glycomacropeptide, a low-phenylalanine whey protein, provide a new alternative to amino Acid-based medical foods for nutrition management of phenylketonuria.

Authors:  Sandra C van Calcar; Denise M Ney
Journal:  J Acad Nutr Diet       Date:  2012-08       Impact factor: 4.910

3.  Favourable outcome in a child with symptomatic diagnosis of Glutaric aciduria type 1 despite vertical HIV infection and minor head trauma.

Authors:  Angeline Thomas; Els F M Dobbels; Priscilla E Springer; Christelle Ackermann; Mark F Cotton; Barbara Laughton
Journal:  Metab Brain Dis       Date:  2018-02-09       Impact factor: 3.584

4.  Toxic Synergism Between Quinolinic Acid and Glutaric Acid in Neuronal Cells Is Mediated by Oxidative Stress: Insights to a New Toxic Model.

Authors:  Paula Pierozan; Ana Laura Colín-González; Helena Biasibetti; Janaina Camacho da Silva; Angela Wyse; Moacir Wajner; Abel Santamaria
Journal:  Mol Neurobiol       Date:  2017-09-21       Impact factor: 5.590

5.  Cobalamin C defect presenting as severe neonatal hyperammonemia.

Authors:  Diego Martinelli; Andrea Dotta; Laura Massella; Stefano Picca; Alessandra Di Pede; Sara Boenzi; Chiara Aiello; Carlo Dionisi-Vici
Journal:  Eur J Pediatr       Date:  2010-12-10       Impact factor: 3.183

6.  Cerebrospinal fluid alterations of the serotonin product, 5-hydroxyindolacetic acid, in neurological disorders.

Authors:  Elisa De Grandis; Mercedes Serrano; Belén Pérez-Dueñas; Aida Ormazábal; Raquel Montero; Edvige Veneselli; Mercè Pineda; Verónica González; Francesc Sanmartí; Carmen Fons; Anna Sans; Bru Cormand; Luis Puelles; Antonia Alonso; Jaime Campistol; Rafael Artuch; Angels García-Cazorla
Journal:  J Inherit Metab Dis       Date:  2010-09-18       Impact factor: 4.982

7.  Mitochondrial acetoacetyl-CoA thiolase deficiency: basal ganglia impairment may occur independently of ketoacidosis.

Authors:  Stéphanie Paquay; Agnès Bourillon; Samia Pichard; Jean-François Benoist; Pascale de Lonlay; Dries Dobbelaere; Alain Fouilhoux; Nathalie Guffon; Isabelle Rouvet; François Labarthe; Karine Mention; Guy Touati; Vassili Valayannopoulos; Hélène Ogier de Baulny; Monique Elmaleh-Bergès; Cécile Acquaviva-Bourdain; Christine Vianey-Saban; Manuel Schiff
Journal:  J Inherit Metab Dis       Date:  2017-03-02       Impact factor: 4.982

8.  Late-onset cobalamin C deficiency Chinese sibling patients with neuropsychiatric presentations.

Authors:  Sheng-Jun Wang; Chuan-Zhu Yan; Yi-Ming Liu; Yu-Ying Zhao
Journal:  Metab Brain Dis       Date:  2018-01-26       Impact factor: 3.584

9.  Oxidative Stress, Disrupted Energy Metabolism, and Altered Signaling Pathways in Glutaryl-CoA Dehydrogenase Knockout Mice: Potential Implications of Quinolinic Acid Toxicity in the Neuropathology of Glutaric Acidemia Type I.

Authors:  Bianca Seminotti; Alexandre Umpierrez Amaral; Rafael Teixeira Ribeiro; Marília Danyelle Nunes Rodrigues; Ana Laura Colín-González; Guilhian Leipnitz; Abel Santamaría; Moacir Wajner
Journal:  Mol Neurobiol       Date:  2015-11-25       Impact factor: 5.590

10.  Improved nutritional management of phenylketonuria by using a diet containing glycomacropeptide compared with amino acids.

Authors:  Sandra C van Calcar; Erin L MacLeod; Sally T Gleason; Mark R Etzel; Murray K Clayton; Jon A Wolff; Denise M Ney
Journal:  Am J Clin Nutr       Date:  2009-02-25       Impact factor: 7.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.